Stock listing

Frankfurt:6UI Arecor Therapeutics PLC Aktie

German listing (Frankfurt) of Arecor Therapeutics PLC · home listing LSE:AREC

Follow Arecor Therapeutics PLC into a list and get an email when it puts out news.

Share price · FWB:6UI

€0.855 EUR 0.000 (0.0%)

Close on Oct 16, 2026

Day range
€0.735 – €0.855 EUROct 16, 2026
Market value
€38.73M EURAt the close on Oct 16, 2026 · price × 45.30M shares outstanding
Arecor Therapeutics PLC logo
Ticker
Frankfurt:6UI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Arecor Therapeutics (LSE:AREC) — Half Year esults for the six months to 30 June 2026

    Mon, Oct 12, 2026 · 9:00 AM ET

    Watch Transcript

  • Arecor Therapeutics (LSE:AREC) Q4 2025 Earnings Call

    Thu, Apr 23, 2026 · 6:00 AM ET

    Watch Transcript

  • Arecor Therapeutics (LSE:AREC) — Arecor Interim Results, Co-development Agreement & Sale of Royalty and Technology Access Fees

    Thu, Oct 02, 2025 · 6:00 AM ET

    Watch Transcript

Latest news

Patents for concentrated ultra-rapid insulins

Oct 15, 2026

Holding(s) in Company

Oct 13, 2026

Half Year Results Investor Presentation

Oct 8, 2026

Result of Retail Offer

Oct 7, 2026

Retail Offer to raise up to £130,000

Sep 30, 2026

Results of Placing

Sep 30, 2026

Close of Accelerated Bookbuild to New Orders

Sep 30, 2026

Proposed Fundraising to raise up to £5.13 million

Sep 30, 2026

Interim results for the six months to 30 June 2026

Sep 30, 2026

AT278 data published in peer-reviewed journal

Aug 13, 2026

All Arecor Therapeutics PLC news

Financings

  • New ordinary shares (Retail Offer Shares)

    Oct 7, 2026 · US$171,735

    Closed: £130,000 raised · GBX 68 a share · Singer Capital Markets +1

    Dealers: Singer Capital Markets (lead), Singer Capital Markets Securities Limited

    Use of proceeds: General working capital and to strengthen the Group's balance sheet

    Announced Sep 30, 2026 · Closed Oct 7, 2026

  • Private placement of new ordinary shares

    Sep 30, 2026 · US$6.61M

    Update: about £5M · GBX 68 a share · Singer Capital Markets

    Dealers: Singer Capital Markets (lead)

    Use of proceeds: Strengthen balance sheet, extend cash runway to December 2027 and fund critical-path insulin development activities

    Announced Sep 30, 2026 · Update Sep 30, 2026

Read by 6ix AI from the company's releases

Decks

Arecor Therapeutics PLC on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 155 in all · newest Oct 15, 2026 · oldest 2021
Calls
9 calls with a replay · 9 with a transcript · latest Oct 12, 2026
Decks
9 decks · latest June 2026

Where Arecor Therapeutics PLC is listed

ListingExchangeCountryCurrency
LSE:AREC · Home listingLSEUnited KingdomGBX
LS Exchange:A3CRY2LS ExchangeGermanyEUR
Lang & Schwarz:A3CRY2Lang & SchwarzGermanyEUR
Dusseldorf:6UIDusseldorfGermanyEUR
Stuttgart:6UIStuttgartGermanyEUR
Frankfurt:6UI · This pageFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Arecor Therapeutics PLC.